The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 26, 2023
Filed:
Aug. 06, 2018
Applicant:
Ardelyx, Inc., Fremont, CA (US);
Inventors:
Gary Luehr, Fremont, CA (US);
Dean Dragoli, Fremont, CA (US);
Michael Leadbetter, Fremont, CA (US);
Tao Chen, Fremont, CA (US);
Jason Lewis, Fremont, CA (US);
Assignee:
Ardelyx, Inc., Fremont, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07J 63/00 (2006.01); A61P 5/44 (2006.01); G02B 5/02 (2006.01); G02B 5/20 (2006.01); G02B 3/00 (2006.01); G02F 1/1335 (2006.01); G02B 27/00 (2006.01);
U.S. Cl.
CPC ...
G02B 5/0294 (2013.01); A61P 5/44 (2018.01); C07J 63/008 (2013.01); G02B 3/0056 (2013.01); G02B 5/0215 (2013.01); G02B 5/201 (2013.01); G02B 27/0018 (2013.01); G02F 1/133502 (2013.01); G02B 5/021 (2013.01); G02B 2207/123 (2013.01); G02F 1/133526 (2013.01);
Abstract
The present invention provides a compound of formula (I) or a salt thereof: (I) wherein X, L, V, R, R, Rand R, are as defined herein. These compounds are inhibitors of 11-hydroxysteroid dehydrogenase type 2 (11-HSD-2) and are used to treat hyperkalemia.
Luehr, Gary. (2023). Glycyrrhetinic acid derivatives for treating hyperkalemia (U.S. Patent No. 11768319). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11768319
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile